0001213900-24-047639.txt : 20240529
0001213900-24-047639.hdr.sgml : 20240529
20240529212508
ACCESSION NUMBER: 0001213900-24-047639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRAVERSA SERGIO
CENTRAL INDEX KEY: 0001565832
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39082
FILM NUMBER: 241000532
MAIL ADDRESS:
STREET 1: 138 CANTERBURY LN
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0508
4
2024-05-24
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001565832
TRAVERSA SERGIO
C/O RELMADA THERAPEUTICS, INC.
2222 PONCE DE LEON BLVD, 3RD FLOOR
CORAL GABLES
FL
33134
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
2.48
2024-05-24
4
A
0
122358
0
A
2024-03-15
2033-12-15
Common Stock
122358
306239
D
Stock Option (right to buy)
2.48
2024-05-24
4
J
0
122358
0
D
2024-03-15
2033-12-15
Common Stock
122358
183881
D
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 122,358 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares.
On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer.
/s/ Sergio Traversa
2024-05-29